Interdos Revenue and Competitors
Estimated Revenue & Valuation
- Interdos's estimated annual revenue is currently $18.5M per year.
- Interdos's estimated revenue per employee is $201,000
Employee Data
- Interdos has 92 Employees.
- Interdos grew their employee count by 19% last year.
Interdos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Pharmacovigilance Officer | Reveal Email/Phone |
2 | Pharmacovigilance Officer | Reveal Email/Phone |
3 | Head Quality Assurance (Qualified Person & Responsible Person) | Reveal Email/Phone |
4 | Jr Pharmacovigilance Officer & Medical Advisor | Reveal Email/Phone |
Interdos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.1M | 75 | 29% | N/A | N/A |
#2 | $1.4M | 7 | 17% | N/A | N/A |
#3 | $19.9M | 99 | 19% | N/A | N/A |
#4 | $1.6M | 8 | 0% | N/A | N/A |
#5 | $18.5M | 92 | 19% | N/A | N/A |
What Is Interdos?
Interdos is part of the Basic Pharma Group located at the Brightlands Chemelot Campus in Geleen, the Netherlands.\n\nInterdos is your trusted partner for Regulatory Affairs (RA), Pharmacovigilance (PV), Quality Assurance (QA), and Laboratory services in the global pharmaceutical industry. With over two decades of expertise, we deliver proven solutions worldwide.\n\nThe team of Interdos is your perfect partner in guiding you through national or international procedures/legislations regarding pharmaceutical RA, QA, PV and laboratory testing. We have the know-how, the equipment, the experience and the network to direct you from development process towards approval and beyond.\n\nFor additional information or to get in touch, please visit our website. We are more than willing to assist you.
keywords:N/A
N/A
Total Funding
92
Number of Employees
$18.5M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Geleen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29.7M | 110 | 6% | N/A |
#2 | $37.9M | 144 | 30% | N/A |